Results 21 to 23 of about 23 (23)
This study updated safety evidence on ICS and LABA use in pregnant women with asthma. After adjusting confounders, there was no association between ICS or LABA use and adverse fetal outcomes. However, high‐dose ICS exposure was associated with a higher risk of congenital anomalies among ICS users.
Yea‐Chwen Wu +3 more
wiley +1 more source
Inhaled Ciclesonide for Community‐Based COVID‐19: A Placebo‐Controlled Randomised Trial
We undertook a double‐blind, placebo‐controlled, randomised community trial of inhaled ciclesonide 320 mcg daily or placebo for 14 days. The primary outcome was time to recovery of symptoms to day 28. There were 189 people randomised and 185 completed treatment; 96% were COVID‐19 vaccinated.
Peter Wark +12 more
wiley +1 more source
Objectives Cerebrospinal fluid (CSF) rhinorrhea involves drainage of CSF through the nasal cavity due to disruption of the skull base, and pneumonitis secondary to CSF aspiration is a lesser‐known complication reported. We present the case of a patient whose pulmonary symptoms and function improved after surgical CSF leak repair. Methods This is a case
Ann O. Birmingham +4 more
wiley +1 more source

